Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effective dose study of nalbuphine combined with propofol anesthesia for painless gastroscopy in elderly patients
ChiCTR2400091583Phase 4Completed
- Sponsor
- Anhui Public Health Clinical Center
- Start
- Oct 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nalbuphine and propofol in None (3 arms), sponsored by Anhui Public Health Clinical Center. Primary endpoints: Propofol ED50 and Nalbuphine ED50. Started Oct 2024; status: completed.
02
Drugs
nalbuphinepropofol
Beyond the preview
Go deeper on ChiCTR2400091583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091583.